Comparative preclinical pharmacokinetics study of 3,3′-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

por Paltsev, Mikhail, Kiselev, Vsevolod, Muyzhnek, Ekaterina, Drukh, Vadim, Kuznetsov, Igor, Pchelintseva, Olga
Publicado 2013

Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)

por Paltsev, Mikhail, Kiselev, Vsevolod, Muyzhnek, Ekaterina, Drukh, Vadim, Kuznetsov, Igor, Pchelintseva, Olga
Publicado 2014

First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepitheli...

por Paltsev, Mikhail, Kiselev, Vsevolod, Drukh, Vadim, Muyzhnek, Ekaterina, Kuznetsov, Igor, Andrianova, Evgeniya, Baranovskiy, Pavel
Publicado 2016

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane’s efficacy and safety in the treatment of CIN: implications for cervical cance...

por Ashrafian, Levon, Sukhikh, Gennady, Kiselev, Vsevolod, Paltsev, Mikhail, Drukh, Vadim, Kuznetsov, Igor, Muyzhnek, Ekaterina, Apolikhina, Inna, Andrianova, Evgeniya
Publicado 2015